Steven Nissen, the chairman of cardiology at the Cleveland Clinic and head of the American College of Cardiology, will present one keystudy that will use ultrasound probes to measure the effect of torcetrapib on plaque in the coronary arteries at the ACC meeting in New Orleans next March.